Varian Medical Systems, Inc. (NYSE:VAR) insider Dow R. Wilson sold 24,000 shares of the company’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $126.73, for a total value of $3,041,520.00. Following the transaction, the insider now directly owns 90,776 shares in the company, valued at approximately $11,504,042.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Varian Medical Systems, Inc. (NYSE VAR) traded up $1.66 during trading on Friday, reaching $114.50. The company’s stock had a trading volume of 928,122 shares, compared to its average volume of 1,081,863. The firm has a market capitalization of $10,453.85, a price-to-earnings ratio of 28.06, a price-to-earnings-growth ratio of 3.32 and a beta of 0.81. Varian Medical Systems, Inc. has a 12 month low of $79.64 and a 12 month high of $130.29.
Varian Medical Systems (NYSE:VAR) last posted its earnings results on Wednesday, January 24th. The medical equipment provider reported $1.06 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.00 by $0.06. Varian Medical Systems had a return on equity of 27.13% and a net margin of 4.27%. The company had revenue of $678.50 million for the quarter, compared to analyst estimates of $633.96 million. During the same quarter in the prior year, the company earned $1.09 earnings per share. Varian Medical Systems’s revenue was up 12.8% compared to the same quarter last year. research analysts predict that Varian Medical Systems, Inc. will post 4.31 EPS for the current year.
VAR has been the topic of a number of recent analyst reports. Citigroup upped their price objective on Varian Medical Systems from $128.00 to $132.00 and gave the stock a “buy” rating in a report on Thursday, January 25th. Zacks Investment Research raised Varian Medical Systems from a “sell” rating to a “hold” rating in a report on Monday, January 29th. BTIG Research reaffirmed a “hold” rating on shares of Varian Medical Systems in a report on Sunday, January 28th. Royal Bank of Canada set a $105.00 price objective on Varian Medical Systems and gave the stock a “hold” rating in a report on Thursday, November 30th. Finally, JPMorgan Chase & Co. upped their target price on Varian Medical Systems from $88.00 to $105.00 and gave the company a “neutral” rating in a report on Thursday, January 25th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $108.44.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.